Get the Stockscreener App
0.001
0.00%
0.00
Molecular Pharmacology USA Ltd. Stock (MLPH) Forecast
The Molecular Pharmacology USA Ltd. (MLPH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0658, representing a +6,480% increase from the current price of $0.001. The highest analyst price target is $0.1123, and the lowest is $0.0193.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MLPH Price Target
Average 0.0802
(+7,920% Upside)
Long-term MLPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Molecular Pharmacology USA Ltd. financial reports and earnings history, Molecular Pharmacology USA Ltd. (MLPH) stock could reach $0.2239 by 2030, $0.4477 by 2040 and $0.7087 by 2050. See the projected annual prices until 2050 of the Molecular Pharmacology USA Ltd. stock below:
- Molecular Pharmacology USA Ltd. (MLPH) is expected to reach an average price of $0.1277 in 2035, with a high prediction of $0.3787 and a low estimate of $0.0637. This indicates an $12,670% rise from the last recorded price of $0.001.
- Molecular Pharmacology USA Ltd. (MLPH) stock is projected to chart a bullish course in 2040, with an average price target of $0.4477, representing an $44,670% surge from its current level. The forecast ranges from a conservative $0.1793 to a sky-high $0.4477.
- Our analysts predict Molecular Pharmacology USA Ltd. (MLPH) to jump 23,110% by 2045, soaring from $0.1159 to an average price of $0.2321, potentially reaching $0.6919. While $0.1159 is the low estimate, the potential upside is significant.
- Molecular Pharmacology USA Ltd. (MLPH) stock is expected to climb by 2050, reaching an average of $0.7087, a $70,770% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.7087 and $0.2837, respectively, highlighting the market's uncertainty.
Molecular Pharmacology USA Ltd. Stock (MLPH) Year by Year Forecast
Molecular Pharmacology USA Ltd. Stock (MLPH) Price Forecast for 2026
The predicted value for Molecular Pharmacology USA Ltd. (MLPH) in 2026 is set at an average of $0.0718. Estimates vary from a peak of $0.1267 to a trough of $0.0169, indicating an +7,080% surge from the present price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2026 | $0.0583 | $0.0193 | $0.1123 | +5,730% |
| August, 2026 | $0.0199 | $0.0199 | $0.1159 | +1,890% |
| September, 2026 | $0.0997 | $0.0401 | $0.0997 | +9,870% |
| October, 2026 | $0.0823 | $0.0205 | $0.1195 | +8,130% |
| November, 2026 | $0.0425 | $0.0211 | $0.1231 | +4,150% |
| December, 2026 | $0.0217 | $0.0217 | $0.1267 | +2,070% |
Molecular Pharmacology USA Ltd. Stock (MLPH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Molecular Pharmacology USA Ltd. (MLPH) is $0.0889, with a high forecast of $0.1555 and a low forecast of $0.0223. This indicates an +8,790% increase from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1087 | $0.0437 | $0.1087 | +10,770% |
| February, 2027 | $0.0673 | $0.0223 | $0.1303 | +6,630% |
| March, 2027 | $0.0229 | $0.0229 | $0.1339 | +2,190% |
| April, 2027 | $0.0918 | $0.0461 | $0.1375 | +9,080% |
| May, 2027 | $0.0943 | $0.0235 | $0.0943 | +9,330% |
| June, 2027 | $0.0485 | $0.0241 | $0.1411 | +4,750% |
| July, 2027 | $0.0247 | $0.0247 | $0.1447 | +2,370% |
| August, 2027 | $0.1237 | $0.0497 | $0.1237 | +12,270% |
| September, 2027 | $0.1015 | $0.0253 | $0.1483 | +10,050% |
| October, 2027 | $0.0521 | $0.0259 | $0.1519 | +5,110% |
| November, 2027 | $0.1168 | $0.0781 | $0.1555 | +11,580% |
| December, 2027 | $0.1327 | $0.0265 | $0.1327 | +13,170% |
Molecular Pharmacology USA Ltd. Stock (MLPH) Price Forecast for 2028
In 2028, Molecular Pharmacology USA Ltd. (MLPH) is projected to reach an average price of $0.1075, with a high projection of $0.1879 and a low estimate of $0.0271. This indicates an +10,650% rise from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0817 | $0.0271 | $0.1591 | +8,070% |
| February, 2028 | $0.0277 | $0.0277 | $0.1627 | +2,670% |
| March, 2028 | $0.111 | $0.0557 | $0.1663 | +11,000% |
| April, 2028 | $0.1135 | $0.0283 | $0.1135 | +11,250% |
| May, 2028 | $0.0581 | $0.0289 | $0.1699 | +5,710% |
| June, 2028 | $0.0295 | $0.0295 | $0.1735 | +2,850% |
| July, 2028 | $0.1477 | $0.0593 | $0.1477 | +14,670% |
| August, 2028 | $0.1207 | $0.0301 | $0.1771 | +11,970% |
| September, 2028 | $0.0617 | $0.0307 | $0.1807 | +6,070% |
| October, 2028 | $0.1384 | $0.0925 | $0.1843 | +13,740% |
| November, 2028 | $0.1567 | $0.0313 | $0.1567 | +15,570% |
| December, 2028 | $0.0961 | $0.0319 | $0.1879 | +9,510% |
Molecular Pharmacology USA Ltd. Stock (MLPH) Price Forecast for 2029
The 2029 price forecast for Molecular Pharmacology USA Ltd. Stock (MLPH) is $0.1264 on average, with a high prediction of $0.2203 and a low estimate of $0.0325. This represents an +12,540% increase from the previous price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0325 | $0.0325 | $0.1915 | +3,150% |
| February, 2029 | $0.1627 | $0.0653 | $0.1627 | +16,170% |
| March, 2029 | $0.1327 | $0.0331 | $0.1951 | +13,170% |
| April, 2029 | $0.0677 | $0.0337 | $0.1987 | +6,670% |
| May, 2029 | $0.0343 | $0.0343 | $0.2023 | +3,330% |
| June, 2029 | $0.1717 | $0.0689 | $0.1717 | +17,070% |
| July, 2029 | $0.1051 | $0.0349 | $0.2059 | +10,410% |
| August, 2029 | $0.0713 | $0.0355 | $0.2095 | +7,030% |
| September, 2029 | $0.16 | $0.1069 | $0.2131 | +15,900% |
| October, 2029 | $0.1447 | $0.0361 | $0.1447 | +14,370% |
| November, 2029 | $0.1105 | $0.0367 | $0.2167 | +10,950% |
| December, 2029 | $0.0373 | $0.0373 | $0.2203 | +3,630% |
Molecular Pharmacology USA Ltd. Stock (MLPH) Price Forecast for 2030
Molecular Pharmacology USA Ltd. Stock (MLPH) is expected to reach an average price of $0.1435 in 2030, with a high forecast of $0.2491 and a low forecast of $0.0379. This signifies an +14,250% surge from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1494 | $0.0749 | $0.2239 | +14,840% |
| February, 2030 | $0.1519 | $0.0379 | $0.1519 | +15,090% |
| March, 2030 | $0.0773 | $0.0385 | $0.2275 | +7,630% |
| April, 2030 | $0.1735 | $0.1159 | $0.2311 | +17,250% |
| May, 2030 | $0.1957 | $0.0391 | $0.1957 | +19,470% |
| June, 2030 | $0.1195 | $0.0397 | $0.2347 | +11,850% |
| July, 2030 | $0.0403 | $0.0403 | $0.2383 | +3,930% |
| August, 2030 | $0.1614 | $0.0809 | $0.2419 | +16,040% |
| September, 2030 | $0.1639 | $0.0409 | $0.1639 | +16,290% |
| October, 2030 | $0.1249 | $0.0415 | $0.2455 | +12,390% |
| November, 2030 | $0.0421 | $0.0421 | $0.2491 | +4,110% |
| December, 2030 | $0.2107 | $0.0845 | $0.2107 | +20,970% |
0.27%
0.34%
Cap:
|
Volume (24h):